USPTO 2015–2025 USPTO PatentsView US Corporation

Asensus Surgical US, Inc.

USPTO PatentsView assignee record — 58 granted patents across 12 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

58
Total patents granted
12
CPC technology areas
12.6
Avg claims per patent
5-year filing velocity

The verdict

Asensus holds 58 US patents across 12 technology areas — rank #5,821 of 50,000 tracked assignees.

#5,821
of 50,000 US assignees by volume
Top 8%
by Innovation Score (53.9/100)
12.6
avg claims per patent

Portfolio overview

Asensus Surgical US, Inc. has been granted 58 US utility patents between 2021 and 2025, placing Asensus Surgical US, Inc. at rank #5,821 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Asensus Surgical US, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 53.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 58 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Asensus Surgical US, Inc.'s 12.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Asensus Surgical US, Inc. against peers pursuing similar technology classes.

How does Asensus compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Asensus holds 58 patents — placing it at rank #5,821 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Asensus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard

Where it ranks

Overall rank by patents

#5,821

Across all tracked assignees

Innovation Score

53.9 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Asensus Surgical US, Inc. hold?
Asensus Surgical US, Inc. holds 58 US granted patents filed between 2021 and 2025, spanning 12 technology areas.
What is Asensus Surgical US, Inc.'s Innovation Score?
Asensus Surgical US, Inc. has an Innovation Score of 53.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Asensus Surgical US, Inc. focus on?
Asensus Surgical US, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 58 patents. The company has filed patents in 12 CPC subclasses total.
Is Asensus Surgical US, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Asensus Surgical US, Inc..
What does claim depth mean for Asensus Surgical US, Inc.'s patents?
Asensus Surgical US, Inc.'s patents average 12.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Asensus Surgical US, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Asensus's 58 grants land it in the top 8% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Asensus ranks #5,821 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B — see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov